| 1/3 | US=9 / Urologia Aragon-Ching JB, Dahut W. Investigational angiogenesis inhibitors. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 225-32. ISBN 978-1-60327-831-7. INIBIDORES DA ANGIOGENESE; ANTIANGIOGENESIS; ENSAIOS CLINICOS; CANCER DE PROSTATA; TIROSINA QUINASES |
| 2/3 | US=49-D / Câncer Linger RMA, Keating AK, Earp HS, Graham DK. TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. In: Woude GFV, Klein G. Advances in cancer research. v.100. Amsterdam: Elsevier, 2008. p. 35-83. ISBN 978-0-12-374358-9. TAM; TIROSINA QUINASES; FUNCOES BIOLOGICAS; SINALIZACAO; TERAPEUTICA; CANCER HUMANO; BIOLOGIA MOLECULAR |
| 3/3 | US=49-B / Câncer Hu J, Zhou GB, Wang ZY, Chen SJ, Chen Z. Mutant transcription factors and tyrosine kinases as therapeutic targets for leukemias: from acute promyelocytic leukemia to chronic myeloid leukemia and beyond. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2007. p. 191-220. ISBN 978-0-12-373896-7. FATORES DE TRANSCRICAO MUTANTES; TIROSINA QUINASES; LEUCEMIAS; LEUCEMIA PROMIELOCITICA AGUDA; LEUCEMIA MIELOIDE CRONICA |